Stochastic Hazard Analysis of Genetic Circuits in iBioSim and STAMINA

A Comparison of Weighted Stochastic Simulation Methods for the Analysis of Genetic Circuits

Rare events are of particular interest in synthetic biology because rare biochemical events may be catastrophic to a biological system by, for example, triggering irreversible events such as off-target drug delivery. To estimate the probability of rare events efficiently, several weighted stochastic simulation methods have been developed. Under optimal parameters and model conditions, these methods can greatly improve simulation efficiency in comparison to traditional stochastic simulation. Unfortunately, the optimal parameters and conditions cannot be deduced a priori. This paper presents a critical survey of weighted stochastic simulation methods. It shows that the methods considered here cannot consistently, efficiently, and exactly accomplish the task of rare event simulation without resorting to a computationally expensive calibration procedure, which undermines their overall efficiency. The results suggest that further development is needed before these methods can be deployed for general use in biological simulations.

Engineering genetic circuits: advancements in genetic design automation tools and standards for synthetic biology

Synthetic biology (SynBio) is a field at the intersection of biology and engineering. Inspired by engineering principles, researchers use defined parts to build functionally defined biological circuits. Genetic design automation (GDA) allows scientists to design, model, and analyze their genetic circuits in silico before building them in the lab, saving time, and resources in the process. Establishing SynBio's future is dependent on GDA, since the computational approach opens the field to a broad, interdisciplinary community. However, challenges with part libraries, standards, and software tools are currently stalling progress in the field. This review first covers recent advancements in GDA, followed by an assessment of the challenges ahead, and a proposed automated genetic design workflow for the future.